Literature DB >> 10382909

Genotype-phenotype analysis in X-linked Emery-Dreifuss muscular dystrophy and identification of a missense mutation associated with a milder phenotype.

J R Yates1, J Bagshaw, V M Aksmanovic, E Coomber, R McMahon, J L Whittaker, P J Morrison, J Kendrick-Jones, J A Ellis.   

Abstract

Direct sequencing of the emerin gene in 22 families with Emery-Dreifuss muscular dystrophy (EMD) revealed mutations in 21 (95%), confirming that emerin mutations can be identified in the majority of families with X-linked EMD. Most emerin mutations result in absence of the protein. In this study three mutations (a missense mutation Pro183Thr and two in-frame deletions removing residues 95-99 and 236-241, respectively) were unusual in being associated with expression of mutant protein. The phenotype in these families was compared in detail with the clinical features in cases with typical null mutations. For the in-frame deletions there were no significant differences. In the family with the missense mutation the phenotype was milder. Age at onset was later for first symptoms and for development of ankle contractures and muscle weakness. These findings have diagnostic implications as well as pointing to functionally important regions of the emerin protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382909

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  17 in total

1.  Pathogenic mutations in genes encoding nuclear envelope proteins and defective nucleocytoplasmic connections.

Authors:  Cecilia Östlund; Wakam Chang; Gregg G Gundersen; Howard J Worman
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-12

Review 2.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 3.  The nuclear envelope: an intriguing focal point for neurogenetic disease.

Authors:  Howard J Worman; William T Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

4.  Identification of an emerin-beta-catenin complex in the heart important for intercalated disc architecture and beta-catenin localisation.

Authors:  Matthew A Wheeler; Alice Warley; Roland G Roberts; Elisabeth Ehler; Juliet A Ellis
Journal:  Cell Mol Life Sci       Date:  2009-12-09       Impact factor: 9.261

5.  Postnatal development of mice with combined genetic depletions of lamin A/C, emerin and lamina-associated polypeptide 1.

Authors:  Yuexia Wang; Ji-Yeon Shin; Koki Nakanishi; Shunichi Homma; Grace J Kim; Kurenai Tanji; Leroy C Joseph; John P Morrow; Colin L Stewart; Willian T Dauer; Howard J Worman
Journal:  Hum Mol Genet       Date:  2019-08-01       Impact factor: 6.150

Review 6.  Molecular Pathology of Laminopathies.

Authors:  Ji-Yeon Shin; Howard J Worman
Journal:  Annu Rev Pathol       Date:  2021-10-21       Impact factor: 23.472

Review 7.  Emerin in health and disease.

Authors:  Adam J Koch; James M Holaska
Journal:  Semin Cell Dev Biol       Date:  2013-12-21       Impact factor: 7.727

Review 8.  Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan.

Authors:  M N Astejada; K Goto; A Nagano; S Ura; S Noguchi; I Nonaka; I Nishino; Y K Hayashi
Journal:  Acta Myol       Date:  2007-12

9.  Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells.

Authors:  Antoine Muchir; Wei Wu; Howard J Worman
Journal:  Biochim Biophys Acta       Date:  2008-11-05

Review 10.  Diagnosis of Cardiac Abnormalities in Muscular Dystrophies.

Authors:  Elisabeta Bădilă; Iulia Ioana Lungu; Alexandru Mihai Grumezescu; Alexandru Scafa Udriște
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.